Latest Earnings Analysis

• Axsome Therapeutics (AXSM) Q1 2023: Availity Prescriptions Surge 298%, Fueling Commercial Ramp
  May 08, 2023 · AXSM
• Acadia (ACAD) Q1 2023: Debut Launch Targets 4,500 Rett Patients, Unlocks Rare Disease Growth Path
  May 08, 2023 · ACAD
• Aclaris Therapeutics (ACRS) Q1 2023: R&D Expenses Jump 58% as Pipeline Execution Intensifies
  May 08, 2023 · ACRS
• ANI Pharmaceuticals (ANIP) Q1 2023: Rare Disease Surge Lifts Guidance by $25M as Generics Outperform
  May 08, 2023 · ANIP
• BAP Q1 2023: Insurance ROE Surges to 36.5% as Retail Risk, Provisions Rise
  May 08, 2023 · BAP
• Alpha Metallurgical Resources (AMR) Q1 2023: Share Count Drops 23% as Buybacks Accelerate Amid Record Production
  May 08, 2023 · AMR
• Akebia (AKBA) Q1 2023: Operating Expenses Cut 50% as EU Approval Unlocks Vatadustat Path
  May 08, 2023 · AKBA
• BioNTech (BNTX) Q1 2023: Oncology Pipeline Expands to 27 Programs as COVID Franchise Targets €5B
  May 08, 2023 · BNTX
• ADEA Q1 2023: Hybrid Bonding Deals Add $117M, Shifting Revenue Model to Long-Term Streams
  May 08, 2023 · ADEA
• Akoustis (AKTS) Q3 2023: 160% Revenue Surge Anchored by XBAR Filter Ramp and CHIPS Act Leverage
  May 08, 2023 · AKTS
• Asure Software (ASUR) Q1 2023: 163% Surge in New Sales Bookings Signals High-Margin Model Shift
  May 08, 2023 · ASUR
• American Axle (AEE) Q1 2023: Electrification Backlog Hits 40%, Signaling Long-Term Shift
  May 05, 2023 · AEE
• AMC (AMC) Q1 2023: Premium Format Revenue Jumps to 29%, Fueling Margin Upside
  May 05, 2023 · AMC
• Arbor Realty Trust (ABR) Q1 2023: Dividend Raised 5% as Agency Origination Hits $1.1B
  May 05, 2023 · ABR
• Alamo Group (ALG) Q1 2023: Backlog Climbs 8% as Margin Expansion Accelerates
  May 05, 2023 · ALG
• Barron's BDC (BBDC) Q1 2023: Middle Market Portfolio Climbs to 61% of Assets, Anchoring Defensive Yield Strategy
  May 05, 2023 · BBDC
• Boise Cascade (BCC) Q1 2023: BMD Margins Fall 320bps as Commodity Mix Shifts
  May 05, 2023 · BCC
• ACCO (ACCO) Q1 2023: Margin Rate Expands 250bps as Cost Actions Offset Volume Decline
  May 05, 2023 · ACCO
• AMH Q1 2023: Dispositions Top $185M as Capital Recycling Fuels Growth Amid Leasing Surge
  May 05, 2023 · AMH
• ACMR Q1 2023: Gross Margin Jumps to 54% on Product Mix Shift, China Demand Drives Outlook
  May 05, 2023 · ACMR
• AES (AES) Q1 2023: $357M Warrior Run Monetization Underscores Capital Recycling Shift
  May 05, 2023 · AES
• AIG (AIG) Q1 2023: Dividend Up 12.5% as Commercial Lines Drive Double-Digit Premium Growth
  May 05, 2023 · AIG
• Agri Realty (ADC) Q1 2023: Acquisition Guidance Lifted 20% on Seller Capitulation Surge
  May 05, 2023 · ADC
• Advance Six (ASIX) Q1 2023: Granular Ammonium Sulfate Expansion Targets 75% Conversion by 2027
  May 05, 2023 · ASIX
• BlackLine (BL) Q1 2023: Strategic Products Drive 26% of Sales Amid Elongated Deal Cycles
  May 04, 2023 · BL
• A10 Networks (ATEN) Q1 2023: EBITDA Margin Expands to 26.8% Despite 8% Revenue Drop
  May 04, 2023 · ATEN
• ATI (ATI) Q1 2023: Aerospace and Defense Mix Jumps 1,200bps, Unlocking Margin Upside
  May 04, 2023 · ATI
• Bumble (BMBL) Q1 2023: Bumble App Net Ads Top 98,000, Underscoring International Expansion Leverage
  May 04, 2023 · BMBL
• Apple (AAPL) Q2 2023: Services Revenue Hits $20.9B as Installed Base Surpasses 2 Billion Devices
  May 04, 2023 · AAPL
• Applied Optoelectronics (AAOI) Q1 2023: Microsoft 400G Laser Deal Secures $4M R&D Funding Amid CATV Inventory Drag
  May 04, 2023 · AAOI
• AAON (AAON) Q1 2023: $400M Capacity Expansion Targets Surging Backlog and Outpaces Industry Slowdown
  May 04, 2023 · AAON
• AbCellera (ABCL) Q1 2023: R&D Spend Jumps $26M as Platform Integration Deepens
  May 04, 2023 · ABCL
• Arbutus Biopharma (ABUS) Q1 2023: Cash Burn Cut by $5M as Pipeline Milestones Stack Up
  May 04, 2023 · ABUS
• ACI Worldwide (ACIW) Q1 2023: Recurring Revenue Up 9% as License Timing Shifts Margin Profile
  May 04, 2023 · ACIW
• Acres Commercial Realty (ACR) Q1 2023: $64M Portfolio Runoff Sharpens Focus on High-Spread Loan Reinvestment
  May 04, 2023 · ACR
• Enact (ACT) Q1 2023: Persistency Hits 85%, Offsetting 30% NIW Drop
  May 04, 2023 · ACT
• Agios (AGIO) Q1 2023: Persistency Drives 14% Patient Growth as PK Activator Pipeline Hits Enrollment Milestones
  May 04, 2023 · AGIO
• Arteris (AIP) Q1 2023: FlexNOC 5 Launch Targets 20% ACV Growth Amid Automotive and AI Tailwinds
  May 04, 2023 · AIP
• Albemarle (ALB) Q1 2023: Lithium Volumes Up 30% as Contract Structure Shields Volatility
  May 04, 2023 · ALB
• Alico (ALCO) Q2 2023: Florida Orange Crop Plunges 61%, Forcing Strategic Reset
  May 04, 2023 · ALCO
• Alignment Healthcare (ALHC) Q1 2023: Membership Surges 16.5% as Risk Model Shift Drives Competitive Tailwind
  May 04, 2023 · ALHC
• Allstate (ALL) Q1 2023: Auto Rate Hikes Reach 17% as Loss Severity Persists
  May 04, 2023 · ALL
• Alnylam (ALNY) Q1 2023: TTR Franchise Surges 75% in U.S., CNS RNAi Data Opens New Pipeline Horizons
  May 04, 2023 · ALNY
• AMN Healthcare (AMN) Q1 2023: Language Services Up 25% as Travel Nurse Demand Bottoms Out
  May 04, 2023 · AMN
• AMTX Q1 2023: $49.8M Revenue Decline Spotlights Keys Plant Reset and India Biodiesel Ramp
  May 04, 2023 · AMTX
• Angel Oak Mortgage REIT (AOMR) Q1 2023: Expense Base Cut by $2.5M Drives Margin Reset
  May 04, 2023 · AOMR
• Artivion (AORT) Q1 2023: ONIX Platform Grows 24%, Fueling Raised Guidance and Margin Leverage
  May 04, 2023 · AORT
• AOSL Q3 2023: Silicon Carbide Licensing Adds $45M Revenue Stream Amid 35% Top-Line Drop
  May 04, 2023 · AOSL
• APA (APA) Q1 2023: $100M CapEx Cut Signals Fast-Pivot Discipline Amid Volatile Gas Markets
  May 04, 2023 · APA
• APG (APG) Q1 2023: Inspection Revenue Hits Record, Driving Double-Digit Organic Growth
  May 04, 2023 · APG